You are here

P&T News

October 9

Device billed as smallest, lightest responsive therapy for drug-resistant epilepsy
Potential new indication addresses EGFR mutation-positive NSCLC

October 6

Cobas Zika test is made by Roche Molecular Systems

October 5

New trial ordered in dispute between Amgen and Sanofi/Regeneron
Rapid testing approach may help speed effective treatment
First human trial shows progress toward preventing infections

October 4

Two formulations of MS drug earn Teva more than $4 billion

October 3

Presentation of the treatment may be as important as the treatment itself
Research identifies consequences of integrated sepsis screening and treatment
Vaccine uses proteins found in core of virus rather than on its surface
The inhaled therapy treats fungal infections in the lungs

October 2

Drug-device combos and some injectable drugs fall into this class
Work on MK-3682B and MK-3682C discontinued

September 29

Treatment targets advanced or metastatic HR-positive, HER2-negative cases
Novo Nordisk modifies NovoLog with niacinamide

September 28

Medication can launch in Europe a year from now
The cause, they said, involved an average of at least seven factors
Mobile reader gets measurements from sensor wire beneath the skin

Pages